Research Advances Understanding of MSH6’s Impact on PARP Inhibitor Efficacy
Research conducted by Dr. Ou Deng at Moffitt Cancer Center highlights the role of MSH6 in influencing the effectiveness of PARP inhibitors for patients diagnosed with BRCA-proficient high-grade serous ovarian…